Eledon Pharmaceuticals (ELDN) Interest Coverage Ratio (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted Interest Coverage Ratio of 211.81 for Q1 2026, down 783.0% on a QoQ basis from 23.99 in Q3 2025, and down 1067.29% year-over-year from 21.9 in Q1 2025.
Eledon Pharmaceuticals (ELDN) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 211.81 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 1067.29% year-over-year to 211.81 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 205.32 (down 161.69% YoY) and the FY2025 annual result came in at 0.28, up 118.17% from the prior year.
- Interest Coverage Ratio was 211.81 for Q1 2026 at Eledon Pharmaceuticals, down from 23.99 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 12.27 in Q3 2022 and bottomed at 605.03 in Q4 2022.
- A 5-year average of 101.45 and a median of 31.81 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 99.53% — and 2026, when it slumped 1067.29%.
- Eledon Pharmaceuticals' Interest Coverage Ratio stood at 605.03 in 2022, then jumped by 82.74% to 104.42 in 2023, then tumbled by 123.11% to 232.98 in 2024, then surged by 89.7% to 23.99 in 2025, then slumped by 783.0% to 211.81 in 2026.
- Business Quant data shows ELDN's Interest Coverage Ratio at 211.81 in Q1 2026, 23.99 in Q3 2025, and 27.7 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Eledon Pharmaceuticals | 399.11 Mn | 399.11 Mn | - | -211.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -211.81 |
| Sep 30, 2025 | -23.99 |
| Jun 30, 2025 | -27.70 |
| Mar 31, 2025 | -18.15 |
| Dec 31, 2024 | -232.98 |
| Sep 30, 2024 | -35.92 |
| Jun 30, 2024 | -21.55 |
| Mar 31, 2024 | -37.87 |
| Dec 31, 2023 | -104.42 |
| Sep 30, 2023 | -22.99 |
| Jun 30, 2023 | -17.70 |
| Mar 31, 2023 | -133.86 |
| Dec 31, 2022 | -605.03 |
| Sep 30, 2022 | -12.27 |
| Jun 30, 2022 | -15.32 |
| Mar 31, 2022 | -101.64 |
| Dec 31, 2021 | -151.37 |
| Sep 30, 2021 | -2,626.50 |
| Jun 30, 2021 | -28.99 |
| Mar 31, 2021 | -183.78 |